Episode Summary
Executive Summary: The episode is a compilation of Q3 2025 investor-letter readings from three funds, emphasizing how concentrated, high-conviction portfolios are navigating a market dominated by AI enthusiasm, expensive valuations, and sector rotations. The managers argue that their underperformance or outperformance is driven by business fundamentals and specific catalysts, not index-like behavior, and they highlight several idiosyncratic opportunities: BDX, BKTI, LFCR, CLBT, KKR, HGTY, KFS, and PAR.
Main Topics: Macro backdrop: market exuberance amid political and economic uncertainty (Priority: 5/5): The letter opens by contrasting severe macro/political risks with calm equity markets, arguing that the S&P 500 and credit markets are pricing in an unusually optimistic outcome despite weak sentiment, high inflation, and policy volatility. AI boom as an economic and market force (Priority: 5/5): The transcript argues that generative AI spending is propping up both the economy and equity markets through massive CapEx, venture funding, infrastructure buildout, and wealth effects, while creating concentration risk and valuation froth. Hind Group: BDX special situation spin-off and capital returns (Priority: 5/5): Hind Group introduces a new BDX position tied to a reverse Morris Trust with Waters, arguing that the transaction unlocks value, improves focus, and supports buybacks for an almost-great, recession-resistant business. Atai Capital: BK Technologies as a CEO-led share-gain story (Priority: 5/5): Atai highlights BKTI as an exceptional operator turnaround in mission-critical radios, stressing market share gains, pricing power, and a long runway as the company expands beyond its historical wildfire niche. Greenhaven Road: concentrated portfolio, valuation compression, and long-term catalysts (Priority: 5/5): Greenhaven explains underperformance by noting lack of AI direct exposure and its concentration in software/alt managers that have derated, while defending holdings like LifeCore, Celebrite, KKR, Haggerty, Kingsway, and PAR on business progress and upside potential. PAR Technologies: delayed growth as a set-up for future acceleration (Priority: 4/5): The appendix argues PAR’s growth slowdown is temporary and caused by timing shifts in major restaurant RFPs and implementations, with potential wins like McDonald's offering substantial upside if the company executes.
Key Arguments: Markets are pricing in a low-probability-of-failure outcome despite tariffs, inflation, weak sentiment, and fiscal strain; credit spreads and equities look complacent. AI-related capital spending is large enough to materially influence GDP, capital markets, and investor psychology, with benefits extending beyond tech stocks into infrastructure and financing. BDX is attractive because the spin-off monetizes a lower-growth segment at a high valuation, leaving a stronger, cheaper, more focused core medical products business plus buyback support. BKTI’s business quality is improving under strong management; low-cost, mission-critical radios create pricing power, customer loyalty, and long-term share gains from incumbents. Greenhaven’s underperformance stems from being underexposed to AI winners and overweight in unpopular sectors, but its holdings have business-specific catalysts that are not reflected in share prices. Software and alternative asset managers may remain out of favor, but companies with durable products, strong management, and recurring revenue can outperform eventually. PAR’s weak share price reflects timing and multiple compression more than deterioration in the business; deferred implementations and large RFPs could reaccelerate growth. KKR remains attractive because it is diversified beyond private equity, benefits from secular growth in private markets, and has insider alignment and scale advantages. HGTY could see earnings compound dramatically as state-farm partnership economics improve, operating leverage rises, and loss ratios normalize. KFS is positioned as an efficient way to access search-fund style investing at scale, with management quality as the main underwriting factor.
Data Points: Hind Group Q3 net return: 13.93% - Third-quarter 2025 net performance Hind Group YTD net return: 34.91% - Year-to-date performance through Q3 2025 Hind Group annualized net return since inception: 21.24% - Since inception on 8/1/2015 S&P 500 annualized return since 1881 comparison: 14% - Benchmark cited for context Big Tech AI CapEx in 2025: more than $300 billion - Google, Microsoft, Amazon, and Meta projected spending AI infrastructure funding share from other sources: about half - Remaining funding comes from real estate equity/debt, JV financing, securitizations, etc. VC funding into AI startups: $192.7 billion - Through first nine months of 2025 S&P 500 Shiller CAPE: 38.85 - Third-quarter ending valuation, 99th percentile since 1881 Hind Group portfolio cash: ~6% - End of quarter cash allocation Hind Group equity exposure: ~94% - End of quarter portfolio invested in equities BDX biosciences/diagnostics revenue share: 15% - Business being monetized in reverse Morris Trust BDX cash consideration from transaction: $4 billion - Cash to BD funded by newly issued debt BDX stock consideration value: roughly $18.8 billion - Total consideration to BD and shareholders at cited Waters price BDX implied value per BDX share from deal: roughly $65 per share - Estimated value of transaction proceeds per share BDX current trading multiples: 3.4x revenue; 13x P/E - Pre-transaction comparison New BD pro forma valuation: less than 10x fiscal 26 earnings - Post-divestiture valuation argument Atai Q3 net gain: 10.7% - Third-quarter 2025 net performance Atai YTD gain: 43.3% - Year-to-date performance Atai inception gain: 84% - Cited since inception figure Atai portfolio small-cap exposure: 58% below $500 million market cap - Portfolio composition as described Atai top five position concentration: 58% of portfolio - Concentrated portfolio structure BKTI share price: $65 today - At the time of the letter BKTI enterprise value: $220 million - At the time of the letter BKTI potential revenue at 10% market share: ~$230 million - Management long-term target scenario BKTI potential unlevered free cash flow at ~$200 million revenue: $40-$50 million - Illustrative profitability estimate BKTI implied valuation at 15-20x FCF: $190-$250 per share - Bull-case valuation range Greenhaven Q3 return: approximately -9% - Third-quarter performance Greenhaven YTD return: approximately -9% - Year-to-date performance Altimeter software multiple compression: 10.6x to 7.8x EV/NTM revenue - Medium-growth software companies, start of year to Q3 end CLBT ARR growth expectation: 16%-20% - Expected growth this year vs 25% last year CLBT free cash flow margin: 34% - Highlighted as a strength CLBT customer exposure to federal revenue: 17% - Revenue tied to government/federal customers KKR private equity share of AUM: 22% - Shows diversification beyond PE KKR private credit share of AUM: less than 20% - Limits downside from private credit concerns HGTY insider ownership: nearly 86% - Alignment and ownership structure HGTY expected earnings growth: 5x from 2024 to 2029 - Thesis based on partnerships, leverage, and loss-ratio normalization LFCR shelf offering size: up to $150 million - Market reacted negatively to the shelf registration LFCR market cap at filing: $280 million - Used to show shelf size significance PAR current ARR: $288 million - Quarter-end recurring revenue PAR growth rate change: 20% to 16% - Growth deceleration discussed in appendix PAR potential annual revenue increase from RFPs: about $60 million - Expected annualized increase from multiple large opportunities PAR implied valuation at current multiple: more than a double - Upside if growth normalizes and multiple holds PAR current EV/revenue multiple: about 8x - At quarter end after multiple compression
Pivotal Quotes: "The equity market cannot have cared less about any of it." — Hind Group letter (read by Brandon): Describing how markets ignored severe macro and political risks in Q3 2025 "Our new position in BDX is a good example of how I intend to deliver attractive long term returns despite the froth in many new segments of the equity market and the uncertain outlook for the economy." — Hind Group letter: Explaining why BD is a defensive special situation and a value-oriented addition "I don't think the 15th best idea should be weighted the same as the best idea." — Scott / Greenhaven Road letter: Defense of concentrated portfolio construction and active position sizing
Implications: The episode reinforces that in expensive, AI-led markets, alpha will likely come from stock-specific catalysts, disciplined concentration, and balance-sheet or business-model advantages rather than broad index exposure. It also suggests continued volatility between fundamentals and share prices, especially in software, private markets, and special situations.
About Value Hive
Welcome to The Hive! It's nice in here, isn't it? The Hive is a collection of investors, entrepreneurs, thinkers and individuals dedicated to getting a little smarter each day. If you're a fan of value investing, business models, eclectic success and failure stories -- this is your podcast. Our goal is to provide you the highest quality interviews with new twists on old topics. Fresh perspectives on antiquated ideas. Passionate discourse on all things investing. Join us as we strive to improve a little bit each day: https://macro-ops.com/